Haleon’s pilot run of the screener analysed 1,500 pieces of creative for the Panadol pain relief brand across nine markets.

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

The statement read: “NAFDAC enforcement officers, aided by intelligence from the Nigerian Army’s 15 Field Engineering ...

GSK said it is making its largest manufacturing investment in the US yet, allocating $800 million to upgrade its vaccine ...

GSK (NYSE:GSK) continued losses for a seventh straight session as the stock closed 0.61% lower, at $37.51 on Friday.  The ...

Governor Josh Shapiro and GSK leadership announced the global biopharma company’s major investment of up to $800 million in ...

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

The British pharma is making what it calls its largest U.S. manufacturing investment. Elsewhere, AbbVie expanded a ...

The effort by the Center for Regenerative Medicine of Boston University, Boston Medical Center, and GSK aims to find new ...

GSK (GSK) plc announced what it calls its “largest U.S. manufacturing investment to date.” The up to $800M investment will bring ...

GSK (GSK) announced new preliminary data for AREXVY in adults aged 18-49 at increased risk for lower respiratory tract disease, LRTD, caused by ...

Vaccine manufacturer GSK plans to invest $800 million in its County facility, creating 200 new jobs and expanding its ...